Mehrotra R, Devuyst O, Davies SJ, Johnson DW. The current state of peritoneal dialysis. J Am Soc Nephrol. 2016;27(11):3238–52. https://doi.org/10.1681/ASN.2016010112.
Article CAS PubMed PubMed Central Google Scholar
Mendelssohn DC, Mujais SK, Soroka SD, Brouillette J, Takano T, Barre PE, Mittal BV, Singh A, Firanek C, Story K, Finkelstein FO. A prospective evaluation of renal replacement therapy modality eligibility. Nephrol Dial Transplant. 2009;24(2):555–61. https://doi.org/10.1093/ndt/gfn484.
Thurlow JS, Joshi M, Yan G, Norris KC, Agodoa LY, Yuan CM, Nee R. Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol. 2021;52(2):98–107. https://doi.org/10.1159/000514550.
Olbrich H, Sadik CD, Ludwig RJ, Thaçi BK. Dupilumab in inflammatory skin diseases: a systematic review. Biomolecules. 2023;13(4):634. https://doi.org/10.3390/biom13040634.
Article CAS PubMed PubMed Central Google Scholar
Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour J-P, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NMH, Pirozzi G, Akinlade B. SOLO 1 and SOLO 2 Investigators. two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med. 2016;375(24):2335–48. https://doi.org/10.1056/NEJMoa1610020.
Article CAS PubMed Google Scholar
Blauvelt A, de Bruin-Weller M, Gooderham M, Cather JC, Weisman J, Pariser D, Simpson EL, Papp KA, Hong HC-H, Rubel D, Foley P, Prens E, Griffiths CEM, Etoh T, Pinto PH, Pujol RM, Szepietowski JC, Ettler K, Kemény L, Shumel B. Long-term management of moderate- to severe atopic dermatitis with dupilumab concomitant topical corticosteroids (Liberty AD Chronos): a 1-year, randomized, double-blinded, placebo-controlled, phase 3 trial. Lancet. 2017;389(10086):2287–303. https://doi.org/10.1016/S0140-6736(17)31191-1.
Article CAS PubMed Google Scholar
Ariëns LFM, van der Schaft J, Bakker DS, Balak D, Romeijn MLE, Kouwenhoven T, Kamsteeg M, Giovannone B, Drylewicz J, van Amerongen CCA, Delemarre EM, Knol EF, van Wijk F, Nierkens S, Thijs JL, Schuttelaar MLA, de Bruin-Weller MS. Dupilumab is very effective in a large cohort of difficult-to-treat adult atopic dermatitis patients: first clinical and biomarker results from the BioDay registry. Allergy. 2020;75(1):116–26. https://doi.org/10.1111/all.14080.
Article CAS PubMed Google Scholar
Johnson H, Adler BL, Yu J. Dupilumab for allergic contact dermatitis: an overview of its use and impact on patch testing. Cutis. 2022;109(5):265–7. https://doi.org/10.12788/cutis.0519.
Jay R, Rodger J, Zirwas M. Review of dupilumab-associated inflammatory arthritis: an approach to clinical analysis and management. JAAD Case Rep. 2022;21:14–8. https://doi.org/10.1016/j.jdcr.2021.12.011.
Article PubMed PubMed Central Google Scholar
Bridgewood C, Wittmann M, Macleod T, Watad A, Newton D, Bhan K, Amital H, Damiani G, Giryes S, Bragazzi NL, McGonagle D. T helper 2 IL-4/IL-13 Dual blockade with dupilumab is linked to some emergent T helper 17-type diseases, including seronegative arthritis and enthesitis/enthesopathy, but not to humoral autoimmune diseases. J Invest Dermatol. 2022;142(10):2660–7. https://doi.org/10.1016/j.jid.2022.03.013.
Article CAS PubMed Google Scholar
Guitart J. Dupilumab, atopic dermatitis, and mycosis fungoides-new insights on an evolving story. JAMA Dermatol. 2023;159(11):1177–8. https://doi.org/10.1001/jamadermatol.2023.3846.
Chan MK, Chow L, Lam SS, Jones B. Peritoneal eosinophilia in patients on continuous ambulatory peritoneal dialysis: a prospective study. Am J Kidney Dis. 1988;11(2):180–3. https://doi.org/10.1016/s0272-6386(88)80209-9.
Article CAS PubMed Google Scholar
Patel UO, Fox SR, Moy JN, Korbet SM. Pruritic rash and eosinophilia in a patient receiving peritoneal dialysis. Semin Dial. 2011;24(3):338–40. https://doi.org/10.1111/j.1525-139X.2011.00937.x.
Hatchome N, Shido K, Kikuchi K, Terui H, Oba-Yabana I, Mori T, Yamasaki K, Aiba S. Subcutaneous granulomatous reaction with eosinophil infiltration to a silicone continuous ambulatory peritoneal dialysis Tenckhoff catheter. Contact Dermatitis. 2020;82(2):114–6. https://doi.org/10.1111/cod.13399.
Jo Y-I, Song J-O, Park J-H, Lee J-H, Shin SK. Idiopathic eosinophilic peritonitis in continuous ambulatory peritoneal dialysis: experience with percutaneous catheter placement. Nephrology (Carlton). 2007;12(5):437–40. https://doi.org/10.1111/j.1440-1797.2007.00794.x.
Qingyan Z, Yangyang X, Miao Z, Chunming J. Peritoneal dialysis related eosinophilic peritonitis: a case report and review of the literature. BMC Nephrol. 2023;24(1):10. https://doi.org/10.1186/s12882-022-03027-8.
Article PubMed PubMed Central Google Scholar
Kurihara S, Tani Y, Tateishi K, Yuri T, Kitada H, Sugishita N, Fukuda Y, Ishikawa I, Shinoda A, Hayakawa Y. Allergic eosinophilic dermatitis due to silicone rubber: a rare but troublesome complication of the Tenckhoff catheter. Perit Dial Int. 1985;5(1):65–7. https://doi.org/10.1177/089686088500500118.
Simpson EL, Bruin-Weller M, Flohr C, Ardern-Jones MR, Barbarot S, Deleuran M, Bieber T, Vestergaard C, Brown SJ, Cork MJ, Drucker AM, Eichenfield LF, Foelster-Holst R, Guttman-Yassky E, Nosbaum A, Reynolds NJ, Silverberg JI, Schmitt J, Seyger MMB, Paller AS. When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council. J Am Acad Dermatol. 2017;77(4):623–33. https://doi.org/10.1016/j.jaad.2017.06.042.
Nakayama M, Ishida M, Ogihara M, Hanaoka K, Tamura M, Kanai H, Tonozuka Y, Marshall MR. Social functioning and socioeconomic changes after introduction of regular dialysis treatment and impact of dialysis modality : a multi-centre survey of Japanese patients. Nephrology (Carlton). 2015;20(8):523–30. https://doi.org/10.1111/nep.12482.
Comments (0)